A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf.
Filters
DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics
2020
Nucleic Acids Research
Preserved Fulltext
The Database of Antimicrobial Activity and Structure of Peptides (DBAASP) is an open-access, comprehensive database containing information on amino acid sequences, chemical modifications, 3D structures ...
Furthermore, DBAASP has implemented a structure modelling pipeline that automates the setup, execution and upload of molecular dynamics (MD) simulations of database peptides. ...
These and many other properties of the database make it a comprehensive resource to perform structure-activity relationship studies and to develop models for the de novo design of peptides with desired ...
doi:10.1093/nar/gkaa991
pmid:33151284
fatcat:6m6nixrjr5gqxj3dmptxftkmne
ENNAVIA is an innovative new method which employs neural networks for antiviral and anti-coronavirus activity prediction for therapeutic peptides
[article]
2021
bioRxiv
pre-print
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
As the quantity of sequencing data grows annually, the development of an accurate in silico method for the prediction of peptide antiviral activities is important. ...
Antiviral peptides often possess excellent biological activity and a favourable toxicity profile, and therefore represent a promising field of novel antiviral drugs. ...
Acknowledgements The authors would also like to thank University College Dublin for the Research Scholarship granted to P.B.T. ...
doi:10.1101/2021.03.25.436982
fatcat:cakycirycjac7efsxpz4bhusda
Mechanistic Understanding from Molecular Dynamics in Pharmaceutical Research 2: Lipid Membrane in Drug Design
2021
Pharmaceuticals
Preserved Fulltext
A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf.
In the standard "lock and key" paradigm, only the interaction between the drug and a specific active site of a specific protein is considered; the environment in which the drug acts is, from a biophysical ...
interested in exploring how the tool of MD simulation can be applied to their research and computational scientists interested in exploring the possibility of a pharmaceutical context for their research ...
Author Contributions: All authors have read and agreed to the published version of the manuscript. Funding: This research received no external funding. ...
doi:10.3390/ph14101062
pmid:34681286
pmcid:PMC8537670
fatcat:2ybd7h6hafarfhmh7jf7kahokq